Business Context and Reporting Period
Purple Innovation, Inc. (PRPL), a Delaware corporation, filed this Form 8-K on May 18, 2021, to report the entry into a material definitive agreement. The filing details an underwritten secondary public offering of Class A common stock.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a current report regarding a corporate transaction rather than a periodic financial statement.
- Offering Type: Underwritten secondary public offering.
- Shares Offered: 7,308,792 shares of Class A common stock.
- Over-Allotment Option: Underwriters have a 30-day option to purchase up to 1,096,318 additional shares.
- Proceeds: The Company will not receive any proceeds from the offering; all proceeds go to the Selling Stockholders.
- Selling Stockholders: Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC – Series A, and Coliseum Capital Co-Invest III, L.P.
Material Changes
The primary material change is the execution of an Underwriting Agreement with BofA Securities, Inc. as representative. Additionally, the Company, its CEO (Joseph B. Megibow), CFO (Craig L. Phillips), and Director (Adam Gray) have agreed to a 60-day lock-up period, prohibiting the sale or transfer of their securities from May 18, 2021, subject to limited exceptions.
Guidance, Outlook, and Risks
Outlook: The offering is expected to close on or about May 21, 2021, subject to customary closing conditions.
Risks and Contingencies: The filing includes forward-looking statements regarding the anticipated closing. Risks include the ability of the Company and Selling Stockholders to satisfy closing conditions on a timely basis or at all. The document references risk factors detailed in the Company's Annual Report on Form 10-K filed on March 11, 2021, and amended on May 10, 2021.
Investor Verification Checklist
- Verify the final closing date of the offering (expected May 21, 2021) and whether the over-allotment option was exercised.
- Confirm the total number of shares sold by the Selling Stockholders to assess dilution impact on existing shareholders.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific indemnification terms and covenants.
- Check subsequent filings to ensure the 60-day lock-up period was adhered to by management and directors.